Skip to content
The Kids Research Institute Australia logo

Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions

Tropomyosin receptor kinase (TRK) fusions are detected in less than 2% of central nervous system tumors. There are limited data on the clinical course of affected patients. 

Citation:
Lamoureux AA, Fisher MJ, Lemelle L, …….. Gottardo NG, Dholaria H, et al.. Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions. Clin Cancer Res. 2025;31(3):561-72.

Keywords:
Central nervous systems; genetics; mortality; pathology; therapy; gene fusion; glioma; 

Abstract:
Tropomyosin receptor kinase (TRK) fusions are detected in less than 2% of central nervous system tumors. There are limited data on the clinical course of affected patients.